China must be tough for next Virus fight

BEIJING: The most significant global problem this winter is to fight the COVID-19 pandemic. The surging confirmed cases in the US and Europe, the emergence of new variants of coronavirus and sporadic cases in many parts of China in addition to the accelerated use of vaccines are all reminding us of this fact.
There is no doubt that China has now maintained the best overall anti-epidemic situation. China’s national prevention and control system has repeatedly proven itself effective. As accurate measures are being taken to prevent imported cases and a domestic rebound, the Chinese people have been protected before mass vaccination. At the same time, China is among the leading countries in terms of vaccine research and development. Several Chinese vaccines are in late-stage trials and will be put into use.
The Chinese economy has risen from its lowest ebb and witnessed a stable recovery of growth. While major regions around the world are still facing huge uncertainties, China has performed well on both the anti-epidemic and economic fronts and will maintain such positive momentum.
The advantages of the Chinese system and the country’s economic and technological strength have interacted with each other, unleashing tremendous power this year. The bigger the challenge, the stronger and calmer we become.
Of course, the epidemic fight has proven to be an extremely usual protracted war. Some countries that successfully contained the first wave of the epidemic have now fallen into a serious crisis again. They have offered a lesson for us. Since this autumn and winter, the virus found loopholes in different parts of China in different ways, showing that the virus raging outside China could indirectly add pressure to China’s domestic epidemic prevention efforts. The coronavirus has displayed its ferocity which may ruin the hard-won situation that a country or region has achieved at any time.
Therefore, China must be strictly on guard and defend itself to the last moment. It cannot relax its efforts due to “anti-virus fatigue.”
– The Daily Mail-Global Times News exchange item